Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Sanofi’s Journey & Strategy for Continuous Processing for Small Molecules Flavien Susanne at Sanofi and Sean Bermingham at PSE Ltd In the past decade, there has been a growing interest in the application of continuous processing in the pharmaceutical industry with 100s millions of... 8 months ago | 117 mins Embracing variation: a multi-batch study delivers robust estimates of efficacy Natasha A Karp, PhD, Principal Biostatistician in Discovery Sciences, AstraZeneca Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic... 2 years ago | 36 mins Advances in the Purification of Antisense Oligonucleotides Robert Gronke, Ph.D., Senior Principal Scientist, at Biogen and John Cyganowski, Director of Customer Application, Merck Following on the commercial success of Spinraza® (the first successful treatment for patients with spinal muscular atrophy), antisense oligonucleotide... 7 months ago | 61 mins Single-Use & Stainless Steel BioReactors: Quality Factors for Consideration Dr Trevor Deeks, Principal and Consultant of Deeks Pharmaceutical Consulting Services, LLC Single-use (SU) systems are now in common use in pharmaceutical bioprocessing, as well as in other related technologies such as the manufacture of dia... 5 years ago | 76 mins Creating a Modern DataOps Environment to Drive Analytics Mark Ramsey, [PHD] (Former Chief Data & Analytics Officer, GSK) The application of AI and machine learning to tackle tasks such as drug discovery, customer insight or clinical trial optimization are popular media t... 2 years ago | 30 mins From Early Stage to Late Stage Development: How to Characterize a Perfusion-base Perrine Rouel, Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Sartorius Stedim Biotech Full Title: From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD? The biopharmaceut... 3 years ago | 58 mins Understanding the Propensity of Sequence Variants During Cell Line & Culture... Dr. Lisa Marzilli, Associate Research Fellow and group leader Mass Spectrometry at Pfizer, USA Sequence variants (SVs) are protein isoforms that contain one or more unintended amino acid substitutions. They can arise at a single amino acid site ... 3 years ago | 40 mins
